The lawsuit against Medtronic alleged the company improperly induced physicians to recommend Medtronic devices to treat cardiac rhythmic disease.
The lawsuit was originally filed under the qui tam, or whistle-blower, provision of the False Claims Act.
Medtronic has agreed to pay the settling states a combined $362,362, which will be distributed to those states’ Medicaid programs.
More articles on healthcare industry lawsuits:
Detroit area physician admits providing medically unnecessary chemotherapy as part of $225M fraud scheme
Gilead Sciences faces False Claims Act case alleging defective-drug fraud
7 recent healthcare industry lawsuits, settlements
